Related Experiment Video
Updated: Jan 25, 2026

Examining Recall Memory in Infancy and Early Childhood Using the Elicited Imitation Paradigm
Published on: April 28, 2016
Childhood Lead Poisoning in Wisconsin
Krista Christensen1, Marjorie J Coons1, Reghan O Walsh1
1Wisconsin Childhood Lead Poisoning Prevention Program, Wisconsin Department of Health Services, Division of Public Health, Bureau of Environmental and Occupational Health, Madison, Wisconsin.
Insights
Physicians are crucial for preventing and treating childhood lead exposure. Early detection and intervention are key to mitigating adverse health effects in children with elevated blood lead levels.
Area of Science:
- Environmental Health
- Pediatric Health
- Public Health Policy
Background:
- In 2016, 4,353 Wisconsin children under 6 had elevated blood lead levels (≥ 5 μg/dL).
- No safe blood lead level exists; even levels below 5 μg/dL pose risks for developmental delays.
Purpose of the Study:
- To emphasize the critical role of physicians in addressing childhood lead poisoning.
- To highlight the importance of primary and secondary prevention strategies.
- To underscore the need for improved lead screening and reporting.
Main Methods:
- Review of current guidelines and federal requirements for lead testing.
- Analysis of Wisconsin's Childhood Lead Poisoning Prevention Program data.
- Examination of surveillance data on Medicaid-enrolled children's screening rates.
Main Results:
- Physician education and clinical management are vital for primary and secondary prevention.
- Current lead screening rates are inadequate, with only 32% of Medicaid-enrolled children tested in 2015.
- State statute mandates reporting of all blood lead test results to the Wisconsin Childhood Lead Poisoning Prevention Program.
Conclusions:
- Physicians are essential partners in preventing, identifying, and mitigating lead poisoning effects in children.
- Adherence to testing guidelines, considering child's age, socioeconomic status, and housing, is recommended.
- Enhanced surveillance and physician engagement are necessary to reduce elevated blood lead levels.
Introduction:
In 2016, 4,353 Wisconsin children under 6 years of age were identified with elevated blood lead levels (≥ 5 μg/dL). There is no safe level of lead in the human body; extensive research shows that children with blood lead levels < 5 μg/dL may still be at risk for adverse health effects including developmental delays.
Discussion:
Physicians should follow current guidelines and consider factors such as the child's age, socioeconomic status, and housing situation when determining need for testing. In addition to Wisconsin's screening recommendations, federal requirements exist for testing Medicaidenrolled children. Under state statute, all blood lead test results and specified demographic information must be reported to the Wisconsin Childhood Lead Poisoning Prevention Program. To eliminate elevated blood lead levels, primary prevention is key. Physicians play an important role by educating parents, prospective parents, and caregivers about lead poisoning risks and prevention measures. Physicians are also vital in secondary prevention-mitigating the adverse effects in children already exposed to lead. Secondary prevention requires first identifying children with elevated blood lead levels through appropriate testing. Use of the Wisconsin Blood Lead Registry can alert providers about children with elevated blood lead levels and reduce duplicate testing. Recent surveillance data show current screening is inadequate; in 2015, only 32% of Medicaid-enrolled children received appropriate testing. Physicians should provide clinical management for children with elevated blood levels and their families.
Conclusions:
Physicians are a vital partner in preventing, identifying, and mitigating the effects of elevated blood lead levels for Wisconsin's children.
Related Concept Videos
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Prevention of Further Absorption of Poison
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Erikson's Theory on Socioemotional Development during Childhood
The first four of Erikson's eight...
Phase-lead and Phase-lag Controllers
Piaget's Theory of Cognitive Development from Childhood into Adulthood
Schemata: Building Blocks of Knowledge

